-
Product Insights
NewCoagulation Factor X – Drugs In Development, 2024
The Coagulation Factor X pipeline drugs market research report outlays comprehensive information on the Coagulation Factor X targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Hematological Disorders, Central Nervous System, and Infectious Disease which include indications of Deep Vein Thrombosis (DVT), Venous Thromboembolism, Bleeding And Clotting Disorders, Hemophilia A (Factor VIII Deficiency), Brain Hemorrhage, and Sepsis....
-
Product Insights
NewX Linked Retinitis Pigmentosa GTPase Regulator – Drugs In Development, 2024
The X Linked Retinitis Pigmentosa GTPase Regulator pipeline drugs market research report outlays comprehensive information on the X Linked Retinitis Pigmentosa GTPase Regulator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Ophthalmology which include indications of Retinitis Pigmentosa (Retinitis), and Retinal Degeneration. It also reviews key players involved in X Linked Retinitis Pigmentosa GTPase Regulator targeted therapeutics...
-
Product Insights
NewC-X-C Chemokine Receptor Type 2 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 2 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Respiratory, and Metabolic Disorders which include indications of Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Inflammation, Autoimmune Disorders, Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewC-X-C Chemokine Receptor Type 3 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 3 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Ophthalmology which include indications of Unspecified Cancer, Solid Tumor, Autoimmune Disorders, Unspecified Immunological Disorders, Type 1 Diabetes (Juvenile Diabetes), and Wet (Neovascular /...
-
Product Insights
NewC-X-C Chemokine Receptor Type 1 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 1 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Metabolic Disorders, and Dermatology which include indications of Metastatic Colorectal Cancer, Solid Tumor, Psoriasis, Inflammation, Obesity, Type 1 Diabetes (Juvenile Diabetes), and Hidradenitis Suppurativa. It also...
-
Product Insights
NewC-X-C Chemokine Receptor Type 4 – Drugs In Development, 2024
The C-X-C Chemokine Receptor Type 4 pipeline drugs market research report outlays comprehensive information on the C-X-C Chemokine Receptor Type 4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Infectious Disease, and Dermatology which include indications of Solid Tumor, Oncology, Transplant Rejection, Autoimmune Disorders, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress...
-
Product Insights
NewC-X-3-C Motif Chemokine Receptor – Drugs In Development, 2024
The C-X-3-C Motif Chemokine Receptor pipeline drugs market research report outlays comprehensive information on the C-X-3-C Motif Chemokine Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Oncology, and Immunology which include indications of Myocardial Infarction, Atherosclerosis, Alzheimer's Disease, Secondary Progressive Multiple Sclerosis (SPMS), Ovarian Cancer, Chronic Lymphocytic Leukemia (CLL), and Inflammation. It...
-
Product Insights
NewMicro-X Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Micro-X Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Micro-X Ltd (Micro X) is a company that designs, develops and manufactures a range of innovative, ultra-lightweight, mobile x-ray imaging systems for medical and security applications. The company is headquartered in Tonsley, South Australia, Australia. GlobalData's Medical Devices company profile report, “Micro-X Ltd Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline...
-
Product Insights
Likelihood of Approval Analysis for Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD))
Overview How likely is it that the drugs in Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Overview Adrenoleukodystrophy is a disorder that...
-
Product Insights
X Corp Partner Ecosystem Profile
GlobalData's new report titled "X Corp Partner Ecosystem Profile " serves as a crucial resource for analyzing the partner landscape of X Corp. It identifies the company's partners across various countries and regions, and tracks over 70 data fields including IT solution areas of interest, business fundamental data (such as revenue and employee bands), partner engagement signing country, focused verticals, and more.It is based on data and information gathered from a range of sources including company websites, press releases, CXO...